Felipe Melo Cruz

13PUBLICATIONS
115CO-AUTHORS
Models of care and place of birthPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 24, 2026
Sociodemographic and Clinicopathologic Characteristics of Patients With Invasive Breast Cancer in Latin America: The LATINA Breast Cohort (LACOG 0615/MO39485).

|Aug 13, 2025
Prognostic factors of meningeal carcinomatosis in breast cancer patients.

Flávia de Oliveira Lima, Renata Tortato Meneguetti, Auro Del Giglio

|Jul 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation.

Panagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer

|May 14, 2025
Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer.

Camilla Vieira de Rebouças, Rafaela de Brito Alves, Alayne Magalhães Trindade Domingues Yamada

|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.

Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim

|Mar 27, 2024
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.

Miguel Martín, Elgene Lim, Mariana Chavez-MacGregor

Pageof 3

Frequent Collaborators

6 joint publications

Auro Del Giglio

3 joint publications

Lilian Silva Martins de Arruda

2 joint publications

Camilla Vieira de Rebouças

2 joint publications

Alayne Magalhães Trindade Domingues Yamada